Heart Disease Clinical Trials in Arizona

Showing 381-396 of 396 trials

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

NCT00595673

This trial is to compare PB127 echocardiography to other heart imaging studies.

Point Biomedical428 participantsStarted Jul 2002

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • San Francisco, California, United States +16 more locations

COMPLETEDPhase 231 miles

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

NCT00525954

The study will be conducted at up to 25 U.S. centers and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 2 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.

Coronary Artery Disease

Anthera Pharmaceuticals120 participantsStarted Sep 2007

Mobile, Alabama, United States • Scottsdale, Arizona, United States • Hudson, Florida, United States +10 more locations

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Heart Disease Trials in Other Cities

ARISE - Aggressive Reduction of Inflammation Stops Events

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Other Conditions in Arizona